Updates on Novel Coronavirus Disease 2019 (COVID-19)


Information may change at any time due to the evolving situation.




Updates on COVID-19 Variants

Updates on COVID-19 Vaccines

COVID-19 Case Tracker [ View in full-screen ]

Latest Updates

E.g., 2023/03
Date Time Update
July 26, 2022

Department Circular 2022-0397: Clarification and Updates on the Grant of COVID-19 Health Care Worker Benefits
July 19, 2022

DOH issues Press Release: DOH: General Santos City, 18 other LGUs de-escalated to COVID-19 Alert Level 1 status for July 16 to 31, 2022
Following the directive of the President to retain the COVID-19 Alert Level System (ALS) for now, the Department of Health (DOH) as Chair of the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID) announces that for the period July 16 to 31, 2022, General Santos City, along with 18 other LGUs all over the country are de-escalated to Alert Level 1 status. The DOH noted, based on IATF-EID metrics, that these areas were able to de-escalate by maintaining their case classification and total beds utilization rates at low risk, and reaching or nearing the vaccination thresholds for target population and target A2 (senior citizens) priority group...
June 28, 2022

DOH issues Press Release: DOH urges health facilities to liquidate COVID-19 benefits due healthcare workers
The Department of Health (DOH) once more urges all health facilities to submit all documentary requirements for the grant of healthcare worker benefits related to COVID-19. These include the COVID-19 Risk Exposure Classification (CREC), attestations, and Memorandum of Agreement. Liquidation Reports covering any previously transferred funds from the DOH must also be submitted to the respective DOH Centers for Health Development (CHDs)...
June 27, 2022

Inter-Agency Task Force for the Management of Emerging Infectious Diseases Resolution No. 169-A
June 27, 2022

Inter-Agency Task Force for the Management of Emerging Infectious Diseases Resolution No. 169
June 20, 2022

Department Memorandum No. 2022-0252: Interim Operational Guidelines on the Administration of Additional Doses of Pfizer-BioNTech COVID-19 Vaccine to Immunocompromised Pediatric A3 ages 12 to 17 Years Old

Pages